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Abstract: Xenopus laevis embryos are an established model for studying kidney development.
The nephron structure and genetic pathways that regulate nephrogenesis are conserved between
Xenopus and humans, allowing for the study of human disease-causing genes. Xenopus embryos are
also amenable to large-scale screening, but studies of kidney disease-related genes have been impeded
because assessment of kidney development has largely been limited to examining fixed embryos.
To overcome this problem, we have generated a transgenic line that labels the kidney. We characterize
this cdh17:eGFP line, showing green fluorescent protein (GFP) expression in the pronephric and
mesonephric kidneys and colocalization with known kidney markers. We also demonstrate the
feasibility of live imaging of embryonic kidney development and the use of cdh17:eGFP as a kidney
marker for secretion assays. Additionally, we develop a new methodology to isolate and identify
kidney cells for primary culture. We also use morpholino knockdown of essential kidney development
genes to establish that GFP expression enables observation of phenotypes, previously only described
in fixed embryos. Taken together, this transgenic line will enable primary kidney cell culture and live
imaging of pronephric and mesonephric kidney development. It will also provide a simple means for
high-throughput screening of putative human kidney disease-causing genes.
Keywords: cdh17; pronephros; mesonephros; kidney; nephron; live imaging; primary culture;
Xenopus; transgenic
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1. Introduction
Xenopus laevis is an established vertebrate model for studying developmental processes. X. laevis
produce free-living, relatively transparent embryos, enabling direct visualization of development
during chemical and genetic screens. This, combined with the numerous embryos produced in a single
clutch, allows for hundreds of embryos to be manipulated and observed in a single experiment [1–3].
Additionally, the large size of the embryos and established fate maps allow for targeted microinjection
into a selected blastomere to manipulate gene expression in a tissue of interest [4–9]. This method of
targeted injections directs knockdown or overexpression of genes to a selected subset of tissues in F0
generation embryos. Targeted injections allow for a delivery of constructs to organs of interest, while
avoiding tissues that affect early development and prevent assessment of subsequent phenotypes.
This technique generates tissue-targeted knockdown or knockout mutant embryos similar to the
Cre–LoxP systems commonly used in mouse and zebrafish studies.
Mammalian kidneys go through three developmental stages: the pronephros, mesonephros
and metanephros [10]. Although the mammalian pronephros is non-functional, it is essential for
the subsequent development of the mesonephric and metanephric kidney forms [11]. Each X. laevis
pronephric kidney consists of one functional nephron which runs down the side of the tadpole.
Like nephrons in the mammalian metanephros, the X. laevis pronephros consists of a glomus
(functionally similar to the mammalian glomerulus), as well as proximal, intermediate, distal and
connecting tubules, which together filter waste products and resorb nutrients from the blood [10,12–14].
Additionally, many of the markers that label each region of the kidney are conserved between the
Xenopus pronephros and the mammalian metanephros [15,16].
X. laevis is a useful model for studying processes involved in vertebrate kidney development
and disease [17]. The X. laevis pronephros undergoes rapid development and becomes functional
within 2–3 days after fertilization [18,19]. A number of assays to assess kidney function, such as
development of edema and visualization of the passage of fluorescent molecules through the kidney,
have been developed for use in X. laevis [13,20]. Modulating the function or expression of putative
disease-causing genes through the injection of morpholinos, messenger RNA (mRNA) or clustered
regularly interspaced short palindromic repeats (CRISPR)–Cas9 gene editing constructs results in
kidney developmental phenotypes in X. laevis [21,22]. This allows for further study of the role that
these genes play in human kidney pathologies.
X. laevis is also a useful model for use in stem cell and primary cell culture research. In early
embryos, cells are weakly held together and can be easily dissociated in calcium- and magnesium-free
saline. An established example of this is the animal cap [23]. Additionally, the cells of X. laevis embryos
contain yolk, allowing them to survive in simple saline solutions for days. X. laevis cells can also
survive at temperatures from 15 to 25 ◦C under normal atmosphere, allowing for easy growth without
the need for a special incubator. Given that there are no clear live markers for kidney cells, one
limitation of primary tissue culture of kidney cells in X. laevis is the inability in live cells to identify
cells of interest.
Although the external development of X. laevis embryos allows for live imaging of many
tissues, [24] live imaging of the kidney is difficult because there are currently no live markers.
To facilitate the study of the dynamic cellular movements that occur during nephrogenesis,
we generated a X. laevis transgenic line that labels the kidney cells. Here, we characterized this
cdh17:eGFP line and demonstrate its usefulness in examining kidney development in vivo over a wide
range of developmental stages. We also show that GFP expression within the labeled kidney is
useful for monitoring the effects of targeted microinjection of morpholinos. Additionally, we develop
a method for primary culture of X. laevis kidney cells. This transgenic line allows for live embryonic
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kidney labeling without the need to fix and stain embryos, enabling live observation of X. laevis kidneys
and kidney function during development.
2. Materials and Methods
2.1. Transgenic Animal Generation and Embryo Culture
The cdh17:eGFP [Xla.Tg(Dre.cdh17:eGFP)NXR; RRID:NXR_0.0102] transgenic frog line was
generated by I-SceI mediated integration [25,26]. Approximately a 4.3-kb genomic fragment upstream
of the Danio rerio cdh17 gene was amplified from pTol2(cdh17::eGFP) [27,28] and cloned into the
I-SceIpBSIISK+ vector. GFP-positive transgenic embryos were generated and maintained until sexual
maturity at the National Xenopus Resource (Woods Hole, MA, USA). Transgenic F0 males were crossed
to wild type X. laevis females to generate backcrossed F1 generation animals (Figure 1).
Figure 1. Schematic of cdh17:eGFP transgenic line creation. (A) cdh17:eGFP construct flanked by I-SceI
sites was co-injected with I-SceI meganuclease into one-cell embryos. (B) Eight female and 11 male
Xenopus laevis adults were grown from these F0 embryos. (C) Upon mating of an F0 transgenic male to
a wild type female, 14 F1 females were generated.
Wild type X. laevis adult males were purchased from Nasco (LM00713M, Fort Atkinson, WI,
USA). Embryos were obtained from cdh17:eGFP adult females and reared as previously described [29].
All embryos were grown in 1/3× Marc’s Modified Ringer’s (MMR) (33 mM NaCl, 0.66 mM KCl,
0.33 mM MgSO4, 0.66 mM CaCl2, 1.66 mM HEPES pH 7.4) [29]. This protocol was approved by the
UTHealth’s Center for Laboratory Animal Medicine Animal Welfare Committee, which serves as the
Institutional Animal Care and Use Committee (protocol #: AWC-16-0111).
2.2. Immunostaining
Embryos were staged [19], fixed [9], and immunostained using established protocols [30].
Proximal tubule lumens were labeled with antibody 3G8 (1:30, European Xenopus Resource Centre,
Portsmouth, United Kingdom), while cell membranes of the intermediate, distal and connecting
tubules were labeled with antibody 4A6 (1:5, European Xenopus Resource Centre) [31]. Proximal
tubule lumens were also detected using Fluorescein isothiocyanate (FITC)-conjugated lectin from
Erythrina cristagalli (1:1000, FL-1141 Vector labs, Burlingame, CA, USA). Rabbit anti green fluorescent
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protein (anti-GFP) (1:500, iclLab, Portland, OR, USA) antibody was used to detect GFP expression.
Goat anti-mouse or anti-rabbit conjugated to Alexa Fluor 488, Alexa Fluor 555, or Alexa Fluor 647
(1:2000, Invitrogen, Carlsbad, CA, USA) secondary antibodies were used to visualize antibody staining.
2.3. Imaging
Embryos were scored and imaged using an Olympus SZX16 fluorescent stereomicroscope
(Olympus, Tokyo, Japan) equipped with an Olympus DP71 camera. Confocal kidney images were taken
using a Zeiss LSM800 confocal microscope (Zeiss, Oberkochen, Germany). Fixed embryos were cleared
in a solution of BABB/Murray’s clearing solution (1:2 volume of benzyl alcohol to benzyl benzoate).
For live imaging, animals were anesthetized with 10 µg/mL Benzocaine in 1/3× MMR [32,33].
For time-lapse movies, embryos were immobilized using coverslips anchored down using vacuum
grease [34]. An image was taken every 30 min over a period of 15 h. Images were processed with Zen
blue (Zeiss), Adobe Photoshop, and Microsoft PowerPoint.
2.4. Secretion Assay
Two–4 pulses of 5 nL of 1 mg/mL rhodamine-dextran 10,000 MW (10–20 nL total) was injected
into the coelomic cavity above the heart of benzocaine-anesthetized stage 40–43 embryos [13]. Embryos
were either directly visualized with a dissection microscope, or placed on a confocal microscope for
high resolution imaging.
2.5. Kidney Cell Primary Culture
Animals expressing GFP within the kidney were identified by fluorescent microscopy.
The pronephric primordium was identified by anatomical position and explanted using sharp forceps
from stage 30–32 embryos under white light. All explants were carried out on 2% agar-coated plates.
Approximately 10–20 kidney explants were disassociated in Calcium Magnesium Free Media (CMFM)
[1/3×MMR without MgSO4 and CaCl] for 1 h. Once dissociated cells were washed in Danilchik’s for
Amy (DFA) [53 mM NaCl, 5 mM Na2CO3, 4.5 mM potassium gluconate, 32 mM sodium gluconate,
1 mM CaCl2, 1 mM MgSO4, 0.1% (w/v) BSA, buffered to pH 8.3 with 1 M bicine] and allowed to
attach. Dissociation and attachment procedures were carried out in Attofluor™ Cell Chamber (Thermo
Fisher A7816, Waltham, MA, USA) with fibronectin-coated coverslips (Roche 10838039001, Basel,
Switzerland). Alternatively, to increase the yields of individualized cells, explants were treated with
Trypsin-EDTA (Ethylenediaminetetraacetic acid) (Sigma T4049, St. Louis, MO, USA) for 5 min instead
of CMFM, followed by inactivation of Trypsin-EDTA with 10% fetal calf serum in DFA.
2.6. Microinjection
Microinjections were performed as previously described [9]. 10 nL of injection mix (described
below) was injected into the indicated blastomere. 20 ng of Daam1 morpholino 5′-GCCGCAGGTCTG
TCAGTTGCTTCTA-3′ or Standard morpholino 5′-CCTCTTACCTCAGTTACAATTTATA-3′ were
injected along with 25 ng rhodamine-dextran as a tracer, to mark targeted cells, into the V2 blastomere
at the 8-cell stage to target the kidney [6,35]. Error is given as Standard Error of the Mean (SEM) across
at least three trials.
3. Results
3.1. Generation of Xenopus laevis cdh17:eGFP Line
In zebrafish (Danio rerio), Cadherin-17 (cdh17) is a gene that functions in maintaining pronephric
integrity [36]. Previously, the cdh17 promoter was used to generate a zebrafish transgenic line to
label the pronephric and the mesonephric kidney [27,28]. Given that this promoter was previously
characterized in zebrafish, we confirmed pTol2(cdh17::eGFP) expression in the X. laevis pronephros
in F0 embryos using the Tol2 system [37]. To improve the transgene integration rate into the X. laevis
genome, we cloned the zebrafish cdh17::eGFP fragment into the I-SceIpBSIISK+ vector to generate
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a X. laevis transgenic line [27]. This vector allows for I-SceI-mediated rather than Tol2-mediated
integration. Eight F0 GFP-positive female animals and 11 F0 males were grown until adulthood.
A GFP-positive male was mated to a wild type female to generate 14 F1 generation female animals
(Figure 1). Of the eight F0 females, six animals produced cdh17:eGFP-positive offspring, although
three of the F0 females produced offspring with weak GFP expression. The remaining two F0 animals
produced embryos with undetectable levels of GFP in the kidney. Thirteen of the F1 animals produced
uniformly strong kidney GFP expression, while one F1 female was sterile and did not produce any
eggs. The consistency of GFP expression observed in the embryos of the fertile F1 females was
anticipated given that these females were produced from the same transgenic father and wild type
mother. In contrast, the F0 females produced progeny with a range of GFP intensity, likely due to the
different integration events in each animal.
3.2. cdh17:eGFP Colocalizes with Kidney Markers
To assess the spatial expression of GFP in F2 embryos, we grew tadpoles to stage 40, fixed,
and then stained them with markers of the pronephros. The 3G8 antibody labels the lumen of the
proximal tubules, while the 4A6 antibody labels the cell membranes of the intermediate, distal and
collecting tubules (Figures 2–4) [31]. Additionally, we used Lectin as a marker to further verify
proximal tubules (Video S1) [35]. GFP is expressed in the same cells as these markers, indicating that
the kidney cells are expressing GFP. Additionally, a few tissues other than the kidney weakly expressed
GFP, including the myotome and a population of cells dispersed within the cloaca (Figure 2). However,
in tadpole stages, this expression is weak in comparison with the kidney expression. As predicted,
GFP expression appears to be cytoplasmic and nuclear, since a signal peptide was not included in the
construct (Figure 3).
We find that the cdh17:eGFP transgene is not deleterious to the embryos. The 3G8/4A6 staining in
the transgenic embryos looks similar to their non-transgenic siblings as well as wild type embryos
grown in parallel, suggesting that the transgene does not alter kidney morphology. Additionally,
the transgenic animals do not develop edema, indicating that they have functional kidneys. We also
see that 52% ± 7% (n = 488 embryos) of the embryos had GFP expression in their kidneys. This is
about the predicted rate, given that the transgenic mothers were heterozygous for the transgene,
and the testes used to fertilize the eggs were from wild type X. laevis males. We also find that the
transgenic embryos grow at the same rate as their wild type siblings. Together, our data suggest that
the cdh17:eGFP transgene is not being selected against and is likely not affecting embryo survival or
kidney morphology.
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Figure 2. cdh17:eGFP expression co-localizes with the kidney markers 3G8 and 4A6. Stage 42
cdh17:eGFP transgenic X. laevis embryos were co-immunostained with antibodies for green fluorescent
protein (GFP) and the kidney markers 3G8 and 4A6. (A) GFP immunostained cdh17:eGFP embryo.
(B) 3G8/4A6 immunostained embryo. (C) Merged differential interference contrast (DIC) and
fluorescent image of cdh17:eGFP embryo. Embryo is surrounded in a bubble of 1:2 volume benzyl
alcohol to benzyl benzoate (BABB).
Figure 3. Subcellular GFP expression in the cdh17:eGFP line is largely cytoplasmic and nuclear. Fixed
stage 42 cdh17:eGFP embryos were stained with (A,E) anti-GFP, (B,F) 3G8/4A6, and (C,G) DAPI
(4′,6-diamidino-2-phenylindole). (E–H) Magnified image of proximal tubules.
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Figure 4. cdh17:eGFP labels the kidney throughout pronephric development. Stage 32 through
stage 44, cdh17:eGFP transgenic X. laevis embryos were immunostained with antibodies for GFP and the
kidney markers 3G8 and 4A6. GFP expression is present throughout pronephric kidney development.
(Left) GFP expression, (right) GFP (Green) and 3G8/4A6 (red) kidney marker expression.
3.3. In Vivo Characterization of cdh17:eGFP Transgenic Line
As there is still much to be learned about how the kidney tubules normally develop, we wished
to observe nephrogenesis in real time. To test the feasibility of live imaging of the cdh17:eGFP line,
we anesthetized embryos with benzocaine, immobilized them using coverslips, and then directly
imaged them (Figure 5). cdh17:eGFP is expressed in the developing pronephros between tadpole
stages 30 through 44. We also imaged embryos starting at stage 35 over a period of 15 h (Video S2).
We were able to revive animals by washing them following benzocaine treatment and imaging,
indicating that embryos were not severely harmed in the process.
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Figure 5. Live imaging of kidney development using cdh17:eGFP reporter line. Kidney development
within a transgenic embryo was visualized by GFP expression from stages 30 to 44.
3.4. Assessment of Kidney Function in cdh17:eGFP Embryos
Various dyes, such as 10,000 MW dextrans, are secreted into the urine by the embryonic Xenopus
kidney, allowing for a simple visual readout of kidney function. This is performed by injecting labeled
substances into the coelomic cavity. Uptake of the dye into the kidney can be directly visualized,
followed by excretion of the dye in the urine. It takes approximately five minutes for the dyes to be
secreted and visualized in real time in live embryos, allowing for easy phenotypic determination of
kidney functionality (Video S3). However, coelomic dye injection can result in a strong signal from
the coelomic cavity, making the tubules of the kidney difficult to visualize. The contrast between the
GFP-labeled kidney tubules and the red rhodamine-dextran dye in the cdh17:eGFP line, facilitates the
visualization of the tubules and the localization of the dextran passing through them (Figure 6).
Figure 6. cdh17:eGFP transgenic line labels the kidney for tracking of rhodamine secretion.
Rhodamine-dextran was injected into the coelomic cavity of stage 42 X. laevis embryos and tracked
using GFP as a marker for the kidney.
3.5. Primary Culture of Xenopus laevis Kidney Cells
X. laevis embryos are amenable to dissection and primary cell culture. However, primary
culture of X. laevis kidney cells has not been previously performed. Given that the cdh17:eGFP
expression in the kidney allows for easy tracking of the dissociated cells, we developed a protocol
for culturing kidney cells on coverslips. Similar to animal caps, the cells of the kidney disassociate
in calcium- and magnesium-free media. After disassociation, cells were plated on fibronectin coated
coverslips. The cells attached to the coverslips in a few hours, and were viable for at least 24 h. Kidney
cells were easily detectable by their GFP expression (Figure 7). This 24 h point was chosen as it would
be long enough to assess if our treatment of the cells was acutely toxic, or if the GFP expression reduced
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following explant of the cells without having to use media containing growth factors. GFP expression
did not appear to reduce in strength over the 24 h culture period. The vast majority of explanted cells
appeared healthy by GFP expression. As single cell suspensions were difficult to obtain with this
method, we also utilized Trypsin-EDTA to completely disassociate the cells. We found that the cells
were still viable after treatment, though many cells were lost during the washing steps.
Figure 7. X. laevis cdh17:eGFP transgenic line is useful for primary culture of kidney tubules.
(A) Diagram showing region of embryo that was explanted. (B) Schematic of methodology used
to culture cells. Media used for each step is as indicated DFA (Danilchik’s for Amy) and CMFM
(Calcium Magnesium Free Media). (C) Image of GFP-positive cells cultured for 24 h in DFA. Cells are
outlined using dashed lines.
3.6. Expression of Green Fluorescent Protein in Adult Animals
In zebrafish, the cdh17::eGFP reporter line labels the pronephric as well as the mesonephric
kidneys [28]. To test weather this holds true in X. laevis, we euthanized two F0 and one F1 generation
adult female animals. All of these frogs tested positive for GFP expression within the kidney as
tadpoles, though the two F0 generation animals did not produce GFP-positive offspring, and the F1
generation animal was sterile. We imaged the mesonephric kidneys and found that the cdh17:eGFP
reporter is expressed in tubules within the mesonephric kidney (Figure 8). To ensure that the signal we
observed was not due to background signal, an adult wild type animal kidney was imaged and no
detectable green fluorescent signal was observed.
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Figure 8. X. laevis adult mesonephric tubules express cdh17:eGFP. Adult kidneys were dissected,
then imaged from an F1 generation cdh17:eGFP animal. (A) Brightfield image of X. laevis cdh17:eGFP
kidney. (B,C) GFP fluorescence imaging of cdh17:eGFP kidney. Dashed boxes indicate regions taken for
fluorescence imaging.
3.7. Utility of cdh17:eGFP for Identifying Genes Involved in Kidney Diseases and Development
We next tested the utility of the cdh17:eGFP line to determine genes that result in kidney
malformations. In X. laevis, antisense morpholinos are commonly used to alter gene activity [38].
As many genes that play a role in kidney development also play a role in the development of other
tissues, we microinjected the V2 blastomere to target the kidney progenitors while avoiding most other
tissues [9]. To test the potential of utilizing the cdh17:eGFP transgenic line to identify genes involved in
kidney development, we chose to assess the expression of the cdh17:eGFP reporter upon disruption
of Daam1.
Daam1 is a component of the planar cell polarity pathway, and loss of Daam1 is known to disrupt
tubule morphology [35]. We injected Daam1 or a standard control morpholino into the V2 cell of 8-cell
stage cdh17:eGFP transgenic embryos to target the kidney (Figure 9). The embryos were then fixed
and immunostained with αGFP and 3G8/4A6 antibodies, allowing us to compare the effectiveness
of monitoring GFP expression versus validated kidney markers to assess kidney development [29].
By monitoring the phenotype using GFP expression as a marker for kidney tubules, we were able to
clearly visualize the effects of the morpholino injections on kidney development on the injected side of
the embryos as compared with the uninjected side. Of the 62 transgenic embryos injected with Daam1
morpholino, 62% showed disrupted kidney tubule development, while only 1.4% of the 94 embryos
injected with standard morpholino showed disrupted kidney development. In order to verify that
our Daam1 morpholino was affecting kidney function as well as morphology, we assayed embryos
for the development of edema after knocking down Daam1 in both kidneys: we found that they do
develop edema.
The major advantage of the cdh17:eGFP animals is that kidney development can be directly
visualized in living embryos. This reduces the time, effort, and cost needed to screen for disease-causing
genes. In order to directly compare the efficacy of using living embryos, we injected Daam1 or standard
morpholino and then assayed for abnormal GFP expression (Figure 9). Although the signal intensity
is weaker as compared to the immunostained embryos, we find that immunostained kidneys show
a similar number of abnormal kidneys when compared to living embryos. The added benefit of not
needing to stain the embryos prior to imaging saves approximately three days of processing time,
allowing for faster screening of embryos for phenotypes, and making this transgenic line suitable for
high throughput screening of human kidney development genes.
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Figure 9. Disruption of kidney development using Daam1 morpholino (MO) can be tracked by
cdh17:eGFP. cdh17:eGFP transgenic embryos were injected with Standard or Daam1 morpholino, then
stage 42 embryos were assayed for kidney abnormalities. (A) Representative images of kidneys under
indicated conditions. (B) Percentage of abnormal kidneys under indicated conditions. (C) Daam1
morpholino was injected into both V2 blastomeres, resulting in the development of edema, which
indicates kidney functional defects. Arrow indicates site of edema.
4. Discussion
X. laevis is an attractive model for identifying genes responsible for human diseases [39].
Approximately 79% of genes implicated in human diseases have X. laevis orthologues, including
genes that are involved in human kidney disorders [40]. Many of these disease-causing genes
display phenotypes in the X. laevis pronephric kidney [21], although the mechanisms by which
these disease-causing genes affect kidneys remain unknown. The cdh17:eGFP line allows us to follow
the developmental processes underlying kidney formation as they are occurring, in order to further
understand how kidney defects arise during embryonic development. The rapid development and
large numbers of embryos allows for in vivo and real-time phenotypic assessment of large numbers of
genes in a considerably shorter time than would be possible using mammalian systems.
There is still much to be learned about normal kidney development. This line will allow us
to follow morphogenetic movements within the pronephric and mesonephric kidney throughout
development. The cdh17 promoter drives GFP expression beginning around embryonic stage 30 (early
tadpole stage). This is before the 3G8 and 4A6 antibodies label the pronephros and during a time when
the proximal tubules undergo large developmental changes. Additionally, the cdh17:eGFP reporter
line labels the pronephric as well as the mesonephric kidneys of X. laevis. Little is known about
the pronephric to mesonephric transition, and with this line, we have the potential to monitor these
developmental changes as they occur.
Examining cells in culture provides some advantages when performing certain experiments.
The primary advantage is that it is easier to visualize the staining of subcellular components in cells in
culture. In the whole embryo, visualization of through other tissues may decrease image quality by
blocking and refracting light. Additionally, getting antibodies to penetrate deeply into the embryo
requires chemicals such as methanol or Proteinase K, which may be incompatible with some antibodies
or stains. Additionally, primary cell culture has the advantage that cells can be isolated from external
sources of growth factors. This allows for easier studying of factors that function in specializing cells
into tissues of interest.
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Previously, an immortal kidney cell line (A6) was generated from spontaneous kidney tumor in
X. laevis [41]. Although stable transgenic cell lines have been generated using A6 cells, this process is
frequently difficult, because A6 cells grow slowly and transfection rates are low [42–44]. Additionally,
these cells are a cancerous line that requires growth factors to survive [43]. Here we describe a novel
method of isolating, culturing and identifying primary cell lines using X. laevis. Primary culture of
these kidney cells has advantages over traditional cell culture. Primarily, these non-cancerous cells
allow for better modeling of normal kidney functions. As these cells contain their own yolk, they can
be grown in a saline solution without animal serum. This eliminates many factors that may induce
these cells to take on abnormal characteristics. Additionally, as injections are routine, transfection of
these cells are not necessary. Instead, embryos can be injected with morpholinos, RNAs or CRISPR
constructs, and then the affected kidney cells can be cultured and assayed. GFP expression allows
for confirmation that the cells are kidney cells, and also allows for Fluorescence activated cell sorting
(FACS) analysis of GFP-positive cells, a technique that would not have been feasible before this line
was developed.
We show that GFP is expressed under faithful control of the cdh17 promoter in the kidneys during
organogenesis, and that this expression co-localizes with known kidney markers. We have used
morpholino knockdown of Daam1 to confirm that the GFP expression in the kidney recapitulates
phenotypes described previously in fixed embryos. We also demonstrate that live imaging of kidney
development is feasible with this line, and that GFP expression functions as a reliable marker of kidney
cells in secretion assays. Additionally, we have also developed a novel method for culturing primary
cell lines from X. laevis kidneys. Taken together, this transgenic X. laevis line will be a useful tool,
enabling high throughput screening of putative human kidney disease-causing genes.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/9/4/197/s1,
Video S1: 3D structure of stage 40 cdh17:eGFP X. laevis. Transgene expression labeled using anti-GFP antibody
(green), and Erythrina cristagalli lectin labeling the proximal tubules (red), Video S2: Live imaging of kidney
development starting at stage 38 over a period of 15 h, Video S3: Movie of secretion assay in stage 42 X.
laevis embryo.
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